Athelas
Signal active
Organization
Contact Information
Overview
Athelas develops technology to monitor chronically ill patients in their homes. The company has deployed an FDA-cleared blood diagnostic device along with an array of other sensors to manage Blood Pressure, Weight, Glucose, and Medication Adherence.
About
Industries
Biotechnology, Life Science, Health Care
Founded
2016
Employees
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Athelas headquartered in United States, North America, operates in the Biotechnology, Life Science, Health Care sector. The company focuses on Biotechnology and has secured $9.0B in funding across 60 round(s). With a team of 101-250 employees, Athelas is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Athelas, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
5
Investors
1
Lead Investors
0
Total Funding Amount
$150.1M
Details
5
Athelas has raised a total of $150.1M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Early Stage Venture | 72.0M | ||
| 2017 | Seed | 3.7M | ||
| 2022 | Late Stage Venture | 59.4M | ||
| 2016 | Seed |
Investors
Athelas is funded by 38 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Athelas | - | FUNDING ROUND - Athelas | 59.4M |
| Fifty Years | - | FUNDING ROUND - Fifty Years | 59.4M |
| Athelas | - | FUNDING ROUND - Athelas | undefined |
| CSC Upshot | - | FUNDING ROUND - CSC Upshot | undefined |
Recent Activity
There is no recent news or activity for this profile.